FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Swing-district Democrat faces backlash after vulgar late-night post targeting Trump, doubles down

Trump, Bondi watch historic SCOTUS arguments as justices duel over birthright citizenship

Breaking: Iran Has Requested a Ceasefire, Trump Says

Colorado climber plunges 30 feet after gear ‘failed’ scaling mountainside, rescuers say

Trump Weighing NATO Exit, Slams Alliance as ‘Paper Tiger’ Over Iran Response

Lawmaker says Iran targeted him in phishing attack disguised as TV interview

Florida hospital patient finally leaves room after 5 months amid legal battle

The Votes Are In: JD Vance Absolutely Dominates 2028 GOP Field – 2nd Only to Trump in All Time Support at CPAC

Trump says he’s considering pulling US out of NATO over Iran war stance

Video: Trump Just Fundamentally Changed Mail-in-Voting With 1 Executive Order

White House deploys Marco Rubio to clarify messaging about Iran conflict

April showdowns: 4 key races to watch this month that will test Trump, GOP grip on power

Border Patrol chief Michael Banks hit with prostitution allegations by agents

Trump admin unlawfully terminated legal status of migrants who used Biden-era app, judge rules

Alabama Gov Kay Ivey hospitalized following minor procedure, says she is determined to make speedy recovery

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”